|
1
|
Desai NR and Giugliano RP: Can we predict
outcomes in atrial fibrillation? Clin Cardiol. 35(Suppl 1):
S10–S14. 2012. View Article : Google Scholar
|
|
2
|
Zoni-Berisso M, Lercari F, Carazza T and
Domenicucci S: Epidemiology of atrial fibrillation: European
perspective. Clin Epidemiol. 6:213–220. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leonardi M and Bissett J: Prevention of
atrial fibrillation. Curr Opin Cardiol. 20:417–423. 2005.PubMed/NCBI
|
|
4
|
Harada M, Van Wagoner DR and Nattel S:
Role of inflammation in atrial fibrillation pathophysiology and
management. Circ J. 79:495–502. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pellegrino PL, Brunetti ND, De Gennaro L,
Ziccardi L, Grimaldi M and Biase MD: Inflammatory activation in an
unselected population of subjects with atrial fibrillation: Links
with structural heart disease, atrial remodeling and recent onset.
Intern Emerg Med. 8:123–128. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen MC, Chang JP, Liu WH, Yang CH, Chen
YL, Tsai TH, Wang YH and Pan KL: Increased inflammatory cell
infiltration in the atrial myocardium of patients with atrial
fibrillation. Am J Cardiol. 102:861–865. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Marcus GM, Smith LM, Ordovas K, Scheinman
MM, Kim AM, Badhwar N, Lee RJ, Tseng ZH, Lee BK and Olgin JE:
Intracardiac and extracardiac markers of inflammation during atrial
fibrillation. Heart Rhythm. 7:149–154. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li J, Solus J, Chen Q, Rho YH, Milne G,
Stein CM and Darbar D: Role of inflammation and oxidative stress in
atrial fibrillation. Heart Rhythm. 7:438–444. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Friedrichs K, Adam M, Remane L,
Mollenhauer M, Rudolph V, Rudolph TK, Andrié RP, Stöckigt F,
Schrickel JW, Ravekes T, et al: Induction of atrial fibrillation by
neutrophils critically depends on CD11b/CD18 integrins. PLoS One.
9:e893072014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pinho-Gomes AC, Reilly S, Brandes RP and
Casadei B: Targeting inflammation and oxidative stress in atrial
fibrillation: Role of 3-hydroxy-3-methylglutaryl-coenzyme a
reductase inhibition with statins. Antioxid Redox Signal.
20:1268–1285. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ozaydin M, Icli A, Yucel H, Akcay S, Peker
O, Erdogan D, Varol E, Dogan A and Okutan H: Metoprolol vs.
carvedilol or carvedilol plus N-acetyl cysteine on post-operative
atrial fibrillation: A randomized, double-blind, placebo-controlled
study. Eur Heart J. 34:597–604. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thomsen MB: Strengthening intercellular
communication to prevent atrial fibrillation. Cardiovasc Res.
92:187–188. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gros DB and Jongsma HJ: Connexins in
mammalian heart function. Bioessays. 18:719–730. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rothe S, Busch A, Bittner H, Kostelka M,
Dohmen PM, Mohr FW and Dhein S: Body mass index affects connexin43
remodeling in patients with atrial fibrillation. Thorac Cardiovasc
Surg. 62:547–553. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bikou O, Thomas D, Trappe K, Lugenbiel P,
Kelemen K, Koch M, Soucek R, Voss F, Becker R, Katus HA and Bauer
A: Connexin 43 gene therapy prevents persistent atrial fibrillation
in a porcine model. Cardiovasc Res. 92:218–225. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yan J, Kong W, Zhang Q, Beyer EC, Walcott
G, Fast VG and Ai X: c-Jun N-terminal kinase activation contributes
to reduced connexin43 and development of atrial arrhythmias.
Cardiovasc Res. 97:589–597. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shin SY, Jo WM, Min TJ, Kim BK, Song DH,
Hyeon SH, Kwon JE, Lee WS, Lee KJ, Kim SW, et al: Gap junction
remodelling by chronic pressure overload is related to the
increased susceptibility to atrial fibrillation in rat heart.
Europace. 17:655–663. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Flierl MA, Rittirsch D, Nadeau BA, Chen
AJ, Sarma JV, Zetoune FS, McGuire SR, List RP, Day DE, Hoesel LM,
et al: Phagocyte-derived catecholamines enhance acute inflammatory
injury. Nature. 449:721–725. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu H, Xu M, Wang F, Liu S, Gu J and Lin S:
Chronic stress enhances progression of periodontitis via
α1-adrenergic signaling: A potential target for periodontal disease
therapy. Exp Mol Med. 46:e1182014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Al-Hashem FH, Assiri AS, Shatoor AS,
Elrefaey HM, Alessa RM and Alkhateeb MA: Increased systemic
low-grade inflammation in high altitude native rats mediated by
adrenergic receptors. Saudi Med J. 35:538–546. 2014.PubMed/NCBI
|
|
21
|
The National Academies Collection: Reports
funded by National Institutes of Health, . National Research
Council (US) Committee for the Update of the Guide for the Care and
Use of Laboratory Animals. Guide for the Care and Use of Laboratory
Animals. 8th. National Academies Press (US); Washington (DC): pp.
1–197. 2011
|
|
22
|
Lu Z, Scherlag BJ, Lin J, Niu G, Fung KM,
Zhao L, Ghias M, Jackman WM, Lazzara R, Jiang H and Po SS: Atrial
fibrillation begets atrial fibrillation: Autonomic mechanism for
atrial electrical remodeling induced by short-term rapid atrial
pacing. Circ Arrhythm Electrophysiol. 1:184–192. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rashid A, Hines M, Scherlag BJ, Yamanashi
WS and Lovallo W: The effects of caffeine on the inducibility of
atrial fibrillation. J Electrocardiol. 39:421–425. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bode F, Katchman A, Woosley RL and Franz
MR: Gadolinium decreases stretch-induced vulnerability to atrial
fibrillation. Circulation. 101:2200–2205. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Aviles RJ, Martin DO, Apperson-Hansen C,
Houghtaling PL, Rautaharju P, Kronmal RA, Tracy RP, Van Wagoner DR,
Psaty BM, Lauer MS and Chung MK: Inflammation as a risk factor for
atrial fibrillation. Circulation. 108:3006–3010. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hu YF, Chen YJ, Lin YJ and Chen SA:
Inflammation and the pathogenesis of atrial fibrillation. Nat Rev
Cardiol. 12:230–243. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Boos CJ, Lip GY and Jilma B: Endotoxemia,
inflammation, and atrial fibrillation. Am J Cardiol. 100:986–988.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liuba I, Ahlmroth H, Jonasson L, Englund
A, Jönsson A, Säfström K and Walfridsson H: Source of inflammatory
markers in patients with atrial fibrillation. Europace. 10:848–853.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Goudis CA, Ntalas IV and Ketikoglou DG:
Atrial fibrillation in athletes. Cardiol Rev. 23:247–251. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Saba S, Janczewski AM, Baker LC,
Shusterman V, Gursoy EC, Feldman AM, Salama G, McTiernan CF and
London B: Atrial contractile dysfunction, fibrosis, and arrhythmias
in a mouse model of cardiomyopathy secondary to cardiac-specific
overexpression of tumor necrosis factor-{alpha}. Am J Physiol Heart
Circ Physiol. 289:H1456–H1467. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mitrokhin VM, Mladenov MI and Kamkin AG:
Effects of interleukin-6 on the bio-electric activity of rat atrial
tissue under normal conditions and during gradual stretching.
Immunobiology. 220:1107–1112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Flatland B, Fry MM, LeBlanc CJ and
Rohrbach BW: Leukocyte and platelet changes following low-dose
lipopolysaccharide administration in five dogs. Res Vet Sci.
90:89–94. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
LeBlanc CJ, Horohov DW, Bauer JE, Hosgood
G and Mauldin GE: Effects of dietary supplementation with fish oil
on in vivo production of inflammatory mediators in clinically
normal dogs. Am J Vet Res. 69:486–493. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
LeMay DR, LeMay LG, Kluger MJ and D'Alecy
LG: Plasma profiles of IL-6 and TNF with fever-inducing doses of
lipopolysaccharide in dogs. Am J Physiol. 259:R126–R132.
1990.PubMed/NCBI
|
|
35
|
Cani PD, Amar J, Iglesias MA, Poggi M,
Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, et
al: Metabolic endotoxemia initiates obesity and insulin resistance.
Diabetes. 56:1761–1772. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sparkman NL, Martin LA, Calvert WS and
Boehm GW: Effects of intraperitoneal lipopolysaccharide on Morris
maze performance in year-old and 2-month-old female C57BL/6J mice.
Behav Brain Res. 159:145–151. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Marais M, Maloney SK and Gray DA: The
development of endotoxin tolerance, and the role of
hypothalamo-pituitary-adrenal function and glucocorticoids in Pekin
ducks. J Exp Biol. 214:3378–3385. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wetzel U, Boldt A, Lauschke J, Weigl J,
Schirdewahn P, Dorszewski A, Doll N, Hindricks G, Dhein S and
Kottkamp H: Expression of connexins 40 and 43 in human left atrium
in atrial fibrillation of different aetiologies. Heart. 91:166–170.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sakabe M, Fujiki A, Nishida K, Sugao M,
Nagasawa H, Tsuneda T, Mizumaki K and Inoue H: Enalapril prevents
perpetuation of atrial fibrillation by suppressing atrial fibrosis
and over-expression of connexin43 in a canine model of atrial
pacing-induced left ventricular dysfunction. J Cardiovasc
Pharmacol. 43:851–859. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Elvan A, Huang XD, Pressler ML and Zipes
DP: Radiofrequency catheter ablation of the atria eliminates
pacing-induced sustained atrial fibrillation and reduces connexin
43 in dogs. Circulation. 96:1675–1685. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Thibodeau IL, Xu J, Li Q, Liu G, Lam K,
Veinot JP, Birnie DH, Jones DL, Krahn AD, Lemery R, et al: Paradigm
of genetic mosaicism and lone atrial fibrillation: Physiological
characterization of a connexin 43-deletion mutant identified from
atrial tissue. Circulation. 122:236–244. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Duffy HS and Wit AL: Is there a role for
remodeled connexins in AF? No simple answers. J Mol Cell Cardiol.
44:4–13. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Verheule S, Wilson EE, Arora R, Engle SK,
Scott LR and Olgin JE: Tissue structure and connexin expression of
canine pulmonary veins. Cardiovasc Res. 55:727–738. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ren M, Li X, Hao L and Zhong J: Role of
tumor necrosis factor alpha in the pathogenesis of atrial
fibrillation: A novel potential therapeutic target? Ann Med.
47:316–324. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liew R, Khairunnisa K, Gu Y, Tee N, Yin
NO, Naylynn TM and Moe KT: Role of tumor necrosis factor-α in the
pathogenesis of atrial fibrosis and development of an
arrhythmogenic substrate. Circ J. 77:1171–1179. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sawaya SE, Rajawat YS, Rami TG, Szalai G,
Price RL, Sivasubramanian N, Mann DL and Khoury DS: Downregulation
of connexin40 and increased prevalence of atrial arrhythmias in
transgenic mice with cardiac-restricted overexpression of tumor
necrosis factor. Am J Physiol Heart Circ Physiol. 292:H1561–H1567.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Baumgarten G, Knuefermann P, Nozaki N,
Sivasubramanian N, Mann DL and Vallejo JG: In vivo expression of
proinflammatory mediators in the adult heart after endotoxin
administration: The role of toll-like receptor-4. J Infect Dis.
183:1617–1624. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
48
|
Katoh S, Honda S, Watanabe T, Suzuki S,
Ishino M, Kitahara T, Funayama A, Netsu S, Sasaki T, Shishido T, et
al: Atrial endothelial impairment through Toll-like receptor 4
signaling causes atrial thrombogenesis. Heart Vessels. 29:263–272.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Grisanti LA, Woster AP, Dahlman J, Sauter
ER, Combs CK and Porter JE: α1-adrenergic receptors positively
regulate Toll-like receptor cytokine production from human
monocytes and macrophages. J Pharmacol Exp Ther. 338:648–657. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Spengler RN, Allen RM, Remick DG, Strieter
RM and Kunkel SL: Stimulation of alpha-adrenergic receptor augments
the production of macrophage-derived tumor necrosis factor. J
Immunol. 145:1430–1434. 1990.PubMed/NCBI
|
|
51
|
Panama BK, Latour-Villamil D, Farman GP,
Zhao D, Bolz SS, Kirshenbaum LA and Backx PH: Nuclear factor kappaB
downregulates the transient outward potassium current I(to,f)
through control of KChIP2 expression. Circ Res. 108:537–543. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Richer LP, Vinet A, Kus T, Cardinal R,
Ardell JL and Armour JA: Alpha-adrenoceptor blockade modifies
neurally induced atrial arrhythmias. Am J Physiol Regul Integr Comp
Physiol. 295:R1175–R1180. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yamashita T, Sekiguchi A, Iwasaki YK, Date
T, Sagara K, Tanabe H, Suma H, Sawada H and Aizawa T: Recruitment
of immune cells across atrial endocardium in human atrial
fibrillation. Circ J. 74:262–270. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Verheule S, Van Kempen MJ, te Welscher PH,
Kwak BR and Jongsma HJ: Characterization of gap junction channels
in adult rabbit atrial and ventricular myocardium. Circ Res.
80:673–681. 1997. View Article : Google Scholar : PubMed/NCBI
|
